Management of the Acute Exacerbation of Asthma

References

• Mannino D, Homa D, Akinbami L, Moorman J, Gwynn C, Redd S. Surveillance for asthma–United States, 1980–1999. MMWR 2002; 51: 1–14
   Google Scholar
• National Institutes of Health, National Heart, Lung, and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma 1997. Publ. No. 97-4051
   Google Scholar
• British Thoracic Society. The British Guidelines on Asthma management: 1995 Review and Position Statement. Thorax 1997; 52: S1–21
   PubMedGoogle Scholar
• GINA. Practical Guide for Asthma Management. 1995, http://www.ginasthma.com:80/xprac.html 1995
   Google Scholar
• Holgate ST, Frew AJ. Choosing therapy for childhood asthma. N Engl J Med 1997; 337(23)1690–1692
   Google Scholar
• Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG, Hogg JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100(1)44–51
   PubMed Web of Science ®Google Scholar
• Redington AE, Howarth PH. Airway wall remodelling in asthma. Thorax 1997; 52(4)310–312
   Google Scholar
• Helms PJ. Early environmental influences in the development of asthma and atopic disease. Monaldi Arch Chest Dis 2001; 56(3)265–269
   Google Scholar
• Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324(7340)763–767
   PubMed Web of Science ®Google Scholar
• McFadden ER., Jr, Hejal RB. The pathobiology of acute asthma. Clin Chest Med 2000; 21(2)213–224
   Google Scholar
• Martinez FD. Recognizing early asthma. Allergy 1999; 54(suppl 49)24–28
   PubMed Web of Science ®Google Scholar
• Stein RT, Holberg CJ, Morgan WJ, Wright AL, Lombardi E, Taussig L, Martinez FD. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax 1997; 52(11)946–952
   PubMedGoogle Scholar
• Milgrom H, Wood RI, Ingram D. Respiratory conditions that mimic asthma. Immunol Allergy Clin N Am 1998; 18: 113–132
   Google Scholar
• Idris AH, McDermott MF, Raucci JC, Morrabel A, McGorray S, Hendeles L. Emergency department treatment of severe asthma. Metered-dose inhaler plus holding chamber is equivalent in effectiveness to nebulizer. Chest 1993; 103(3)665–672
   PubMed Web of Science ®Google Scholar
• Closa RM, Ceballos JM, Gomez-Papi A, Galiana AS, Gutierrez C, Marti-Henneber C. Efficacy of bronchodilators administered by nebulizers vs. spacer devices in infants with acute wheezing. Pediatr Pulmonol 1998; 26(5)344–348
   Google Scholar
• Cates C, Rowe B, Bara A. Holding chambers vs. nebulizers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2002; 2, CD000052
   Google Scholar
• Beasley R, Pearce N, Crane J, Burgess C. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality?. J Allergy Clin Immunol 1999; 104(2 Pt 2)S18–30
   Google Scholar
• Anis AH, Lynd LD, Wang XH, King G, Spinelli JJ, Fitzgerald M, Bai T, Pare P. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources. CMAJ 2001; 164(5)625–631
   PubMed Web of Science ®Google Scholar
• Templeton AG, Chapman ID, Chilvers ER, Morley J, Handley DA. Effects of S-salbutamol on human isolated bronchus. Pulm Pharmacol Ther 1998; 11(1)1–6
   PubMedGoogle Scholar
• Baramki D, Koester J, Anderson AJ, Borish L. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol 2002; 109(3)449–454
   PubMedGoogle Scholar
• Cockcroft DW, Davis BE, Swystun VA, Marciniuk DD. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo. J Allergy Clin Immunol 1999; 103(6)1049–1053
   Google Scholar
• Lotvall J, Palmqvist M, Arvidsson P, Maloney A, Ventresca GP, Ward J. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients. J Allergy Clin Immunol 2001; 108(5)726–731
   PubMedGoogle Scholar
• Ahrens R, Weinberger M. Levalbuterol and racemic albuterol: are there therapeutic differences?. J Allergy Clin Immunol 2001; 108(5)681–684
   Google Scholar
• Milgrom H, Skoner DP, Bensch G, Kim KT, Claus R, Baumgartner RA. Low-dose levalbuterol in children with asthma: safety and efficacy in comparison with placebo and racemic albuterol. J Allergy Clin Immunol 2001; 108(6)938–945
   PubMedGoogle Scholar
• Nelson HS, Bensch G, Pleskow WW, DiSantostefano R, DeGraw S, Reasner DS, Rollins TE, Rubin PD. Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma. J Allergy Clin Immunol 1998; 102(6 Pt 1)943–952
   Google Scholar
• Selroos O. Formoterol used as needed–clinical effectiveness. Respir Med 2001; 95(suppl B)S17–S20
   Google Scholar
• Tattersfield AE, Lofdahl CG, Postma DS, Eivindson A, Schreurs AG, Rasidakis A, Ekstrom T. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomized trial. Lancet 2001; 357(9252)257–261
   Google Scholar
• Geelhoed GC, Landau LI, Le Souef PN. Evaluation of SaO2 as a predictor of outcome in 280 children presenting with acute asthma. Ann Emerg Med 1994; 23(6)1236–1241
   Google Scholar
• Chien JW, Ciufo R, Novak R, Skowronski M, Nelson J, Coreno A, McFadden ER, Jr. Uncontrolled oxygen administration and respiratory failure in acute asthma. Chest 2000; 117(3)728–733
   Google Scholar
• O'Driscoll BR, Kalra S, Wilson M, Pickering CA, Carroll KB, Woodcock AA. Double-blind trial of steroid tapering in acute asthma. Lancet 1993; 341(8841)324–327
   Google Scholar
• Rodrigo G, Rodrigo C. Inhaled flunisolide for acute severe asthma. Am J Respir Crit Care Med 1998; 157(3 Pt 1)698–703
   Google Scholar
• Volovitz B, Bentur L, Finkelstein Y, Mansour Y, Shalitin S, Nussinovitch M, Varsano I. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998; 102(4 Pt 1)605–609
   PubMed Web of Science ®Google Scholar
• Schuh S, Reisman J, Alshehri M, Dupuis A, Corey M, Arseneault R, Alothman G, Tennis O, Canny G. A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma. N Engl J Med 2000; 343(10)689–694
   Google Scholar
• Edmonds M, Camargo C, Pollack C, Rowe B. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2001; 1, CD002308
   Google Scholar
• Rowe BH, Bota GW, Fabris L, Therrien SA, Milner RA, Jacono J. Inhaled budesonide in addition to oral corticosteroids to prevent asthma relapse following discharge from the emergency department: a randomized controlled trial. JAMA 1999; 281(22)2119–2126
   PubMed Web of Science ®Google Scholar
• Ratto D, Alfaro C, Sipsey J, Glovsky MM, Sharma OP. Are intravenous corticosteroids required in status asthmaticus?. JAMA 1988; 260(4)527–529
   Google Scholar
• Parameswaran K, Belda J, Rowe B. Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma. Cochrane Database Syst Rev 2000; 4, CD002742
   Google Scholar
• Travers A, Jones A, Kelly K, Barker S, Camargo C, Rowe B. Intravenous beta2- agonists for acute asthma in the emergency department. Cochrane Database Syst Rev 2001; 2, CD002988
   Google Scholar
• Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998; 339(15)1030–1035
   PubMed Web of Science ®Google Scholar
• Rodrigo GJ, Rodrigo C. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Am J Respir Crit Care Med 2000; 161(6)1862–1868
   PubMed Web of Science ®Google Scholar
• Stoodley RG, Aaron SD, Dales RE. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Ann Emerg Med 1999; 34(1)8–18
   Google Scholar
• Rowe B, Bretzlaff J, Bourdon C, Bota G, Camargo C. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000; 2, CD001490
   Google Scholar
• Rodrigo G, Rodrigo C, Pollack C, Travers A. Helium-oxygen mixture for non-intubated acute asthma patients. Cochrane Database Syst Rev 2001; 2
   Google Scholar
• Kress JP, Noth I, Gehlbach BK, Barman N, Pohlman AS, Miller A, Morgan S, Hall JB. The utility of albuterol nebulized with heliox during acute asthma exacerbations. Am J Respir Crit Care Med 2002; 165(9)1317–1321
   Google Scholar
• de Blic J, Delacourt C, Le Bourgeois M, Mahut B, Ostinelli J, Caswell C, Scheinmann P. Efficacy of nebulized budesonide in treatment of severe infantile asthma: a double-blind study. J Allergy Clin Immunol 1996; 98(1)14–20
   PubMed Web of Science ®Google Scholar
• Ilangovan P, Pedersen S, Godfrey S, Nikander K, Noviski N, Warner JO. Treatment of severe steroid dependent preschool asthma with nebulized budesonide suspension. Arch Dis Child 1993; 68(3)356–359
   PubMed Web of Science ®Google Scholar
• Garrett J, Williams S, Wong C, Holdaway D. Treatment of acute asthmatic exacerbations with an increased dose of inhaled steroid. Arch Dis Child 1998; 79(1)12–17
   Google Scholar
• McFadden ER, Jr, Elsanadi N, Dixon L, Takacs M, Deal EC, Boyd KK, Idemoto BK, Broseman LA, Panuska J, Hammons T, Smith B, Caruso F, McFadden CB, Shoemaker L, Warren EL, Hejal RB, Strauss L, Gilbert IA. Protocol therapy for acute asthma: therapeutic benefits and cost savings. Am J Med 1995; 99(6)651–661
   Google Scholar
• Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs. intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest 1996; 110(1)42–47
   Google Scholar
• Schuh S, Parkin P, Rajan A, Canny G, Healy R, Rieder M, Tan YK, Levison H, Soldin SJ. High- vs. low-dose, frequently administered, nebulized albuterol in children with severe, acute asthma. Pediatrics 1989; 83(4)513–518
   PubMed Web of Science ®Google Scholar
• Emerman CL, Cydulka RK. Factors associated with relapse after emergency department treatment for acute asthma. Ann Emerg Med 1995; 26(1)6–11
   Google Scholar
• Emerman CL, Woodruff PG, Cydulka RK, Gibbs MA, Pollack CV, Jr, Camargo CA, Jr. Prospective multicenter study of relapse following treatment for acute asthma among adults presenting to the emergency department. MARC investigators. Multicenter Asthma Research Collaboration. Chest 1999; 115(4)919–927
   PubMed Web of Science ®Google Scholar
• Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, Durocher A, Tonnel AB. Long-term prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146(1)76–81
   Google Scholar
• Newman KB, Mason UG, 3rd, Schmaling KB. Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995; 152(4 Pt 1)1382–1386
   PubMed Web of Science ®Google Scholar
• Wood RP, 2nd, Milgrom H. Vocal cord dysfunction. J Allergy Clin Immunol 1996; 98(3)481–485
   PubMedGoogle Scholar
• Mak H, Johnston P, Abbey H, Talamo R. Prevalence of asthma and health service utilization of asthmatic children in an inner city. J Allergy Clin Immunol 1982; 70(5)367–372
   Google Scholar
• Park CL, Frank AL, Sullivan M, Jindal P, Baxter BD. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. Pediatrics 1996; 98(2 Pt 1)196–200
   PubMed Web of Science ®Google Scholar
• Lieu TA, Quesenberry CP, Jr, Capra AM, Sorel ME, Martin KE, Mendoza GR. Outpatient management practices associated with reduced risk of pediatric asthma hospitalization and emergency department visits. Pediatrics 1997; 100(3 Pt 1)334–341
   PubMed Web of Science ®Google Scholar
• Petty T. Personal communication
   Google Scholar